11.10.2019 • NewsABSDede WillamsRecycling

Styrolution and Bage in ABS Recycling Pact

Styrolution and bage in ABS Recycling Pact (c) Srebrina Yaneva
Styrolution and bage in ABS Recycling Pact (c) Srebrina Yaneva

Ineos Styrolution and Austrian recycler Bage Plastics have agreed to cooperate on producing high-end ABS grades with up to 70% recycled content. Under the deal, the Germany-based Ineos subsidiary will integrate the Austrian processor’s post-consumer recycled electrical and electronic waste into state-of-the-art recycling ABS formulations.

The companies said they have developed the technology to manufacture the ABS recyclate without sacrificing product properties or performance when compared to virgin material and have launched commercial quantities on the market as a drop-in solution for customers.

Sven Riechers, vice president, business management, Standard Products EMEA at Ineos Styrolution, said quality and performance of the recyclate provided by bage plastics “fully meets the standards that we expect for our industry-leading products.” The collaboration, he said will take Styrolution closer to meeting the Ineos group’s target to incorporate least 325,000 t of recycled material into its products annually.

Philipp Baum, General Manager of bage plastics, said both companies share a common vision to support a closed loop economy by maximizing recycling and recovery of materials, thereby minimizing waste and reducing the environment impact.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.